Prostate Cancer - Results from #28280

Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy - Abstract April 8, 2011

Three-dimensional external beam radiotherapy for prostate cancer increases the risk of hip fracture - Abstract April 8, 2011

Does hormone therapy reduce disease recurrence in prostate cancer patients receiving dose-escalated radiation therapy? An analysis of radiation therapy oncology group 94-06 - Abstract April 8, 2011

Discussions about prostate cancer screening between U.S. primary care physicians and their patients - Abstract April 8, 2011

Strategies in castration-resistant prostate cancer - Abstract April 7, 2011

Mortality following bone metastasis and skeletal-related events among men with prostate cancer: A population-based analysis of US Medicare beneficiaries, 1999-2006 - Abstract April 7, 2011

Local insulin-like growth factor-I of ventral prostate was upregulated during long-term castration and may function through the autocrine system - Abstract April 7, 2011

Progensa™ PCA3 test for prostate cancer - Abstract April 7, 2011

Cabazitaxel for the treatment of prostate cancer - Abstract April 7, 2011

How does early detection by screening affect disease progression? Modeling estimated benefits in prostate cancer screening - Abstract April 7, 2011

Feasibility of a pneumatically actuated MR-compatible robot for transrectal prostate biopsy guidance - Abstract April 7, 2011

Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer - Abstract April 7, 2011

Complications of pelvic lymphadenectomy in clinically localised prostate cancer: Different techniques in comparison and dependency on the number of removed lymph nodes - Abstract April 7, 2011

Editor's Commentary - Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression April 7, 2011

Determination of the time for maximal response to neoadjuvant hormone therapy for prostate cancer using magnetic resonance with spectroscopy (MRSI) and dynamic contrast enhancement (DCEMR) - Abstract April 6, 2011

Update on prostate brachytherapy: Long-term outcomes and treatment-related morbidity - Abstract April 6, 2011

Human papillomavirus 16 or 18 infection and prostate cancer risk: A meta-analysis - Abstract April 6, 2011

MiRNA profiles of prostate carcinoma detected by multi-platform miRNA screening - Abstract April 6, 2011

Current and emerging treatment modalities for metastatic castration-resistant prostate cancer - Abstract April 6, 2011

The new biomarkers of prostate cancer - Abstract April 6, 2011

Page 1415 of 1436